Latest News

Adara Bochanis, PharmD Candidate
Death by external causes—primarily accidents and suicide—take the lives of more than 5 million people each year, and it has evolved into a major health concern on a global scale. External causes also include violence, undetermined causes, and medical procedures.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Jill Murphy, Assistant Editor
Louisiana, Nevada, Texas rank highest in flu activity for the month of November.
Jill Murphy, Assistant Editor
In partnership with a team of medical centers, universities, and private industries, Emmes, a scientific research company, will support the development of a “universal influenza vaccine” that could provide longer-lasting protection than the current vaccines available, according to a company press release. The vaccine would also combat a wider variety of influenza viruses.
Jill Murphy, Assistant Editor
Staying on top of oral hygiene may be connected to a lower risk of atrial fibrillation (AF) and heart failure (HF), according to a new study published in the European Journal of Preventive Cardiology.
By Jean Covino, DHSc, MPA, PA-C, and Jennifer Hofmann, MS, PA-C
ATS and IDSA Update Clinical Practice Guidelines for Community-Acquired Pneumonia
Jill Murphy, Assistant Editor
Since 2005, the CDC has enforced National Influenza Vaccination Week to emphasize the importance of continuing flu vaccination even through the winter months. Although it is the holiday season, the CDC and other organizations want to remind the general public that it is never a bad time to get your flu vaccine. Sam Nass, PharmD, MBS and Walgreens Immunizations Manager weighed in on the subject in an interview with Pharmacy Times®.
A study published in September 2019 in the New England Journal of Medicine has found that patients HF with reduced ejection fraction (HFrEF) receiving dapagliflozin decreased their risk of worsening HF or death from cardiovascular causes.
This weekly video program provides our readers with an in-depth review of the latest news, medical product approvals, FDA rulings, and more. The Week in Review highlights a Contemporary Clinic article each week, and is a can't miss for the busy health care professional.
Jill Murphy, Assistant Editor
Starting December 2, midazolam (Nayzilam, UCB) will be available at retail pharmacies for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity that are distinct from a patient’s usual seizure pattern with epilepsy.
Jill Murphy, Assistant Editor
Each November, members of the chronic obstructive pulmonary disease (COPD) community come together to focus on increasing awareness of the respiratory condition.
Kristen Coppock, MA, Managing Editor
The FDA has approved cenobamate tablets (XCOPRI, SK Life Sciences) for treatment of partial-onset seizures in adults.

Features

Feature Focus: Preventive Care

Clinicians should recommend routine yearly influenza vaccinations for everyone 6 months or older who has no contraindications for the 2019-2020 influenza season starting at the end of October, according to the Advisory Committee on Immunization Practices.

Feature Focus: Acute Care

Cancer, diabetes, and heart disease account for a large portion of the $3.3 trillion annual US health care expenditures. In fact, 90% of these expenditures are due to chronic conditions. About 23 million people in the United States have diabetes, 7 million have undiagnosed diabetes, and 83 million have prediabetes.

Feature Focus: Chronic Care

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) defines the condition as follows: “COPD is a common, preventable, and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles or gases.”

Practitioner to Practitioner

There are many different causes of throat discomfort, but patients commonly associate a sore throat with an infection and may think that they need antibiotics. This unfortunately leads to unnecessary antibiotic prescribing when clinicians do not apply evidence-based practice.

Educated Patient

The symptoms associated with colds, most commonly congestion, coughing, sneezing, and sore throats, are the body's response when a virus exerts its effects on the immune system. Cold symptoms peak at about 1 to 2 days and last 7 to 10 days but can last up to 3 weeks.

Practitioner to Practitioner

This article was sponsored by Nature Made Nutritional Products.

The Educated Patient

Katarzyna Lalicata, MSN, FNP-C, FNP-BC
The symptoms associated with colds, most commonly congestion, coughing, sneezing, and sore throats, are the body's response when a virus exerts its effects on the immune system. Cold symptoms peak at about 1 to 2 days and last 7 to 10 days but can last up to 3 weeks.
Kristen L. Marjama, DNP, APRN-BC, FNP
Exposure to damp and moly environments may also result in a variety of other health issues.
Bethany Rettberg, NPC
An accurate medical history and a physical exam are critical to rule out more serious conditions.
Bethany Rettberg, NPC
Practitioners should get a detailed medical history and conduct a thorough physical to treat sinus infections.

Current Issue

$AD300x250BB$
$vacMongoViewPlus$ $vAR$
Contemporary Clinic
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
ONCLive
OTCGuide
Pharmacy Times
Specialty Pharmacy Times
Targeted Oncology
About Us
Advertise
Careers
Contact Us
Feedback
Privacy
Terms & Conditions
Pharmacy Healthcare & Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-257-0701

Copyright Contemporary Clinic 2019
Pharmacy Healthcare & Communications, LLC. All Rights Reserved.